Corient Ia LLC Dr Reddys Laboratories LTD Transaction History
Corient Ia LLC
- $141 Billion
- Q1 2025
A detailed history of Corient Ia LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Corient Ia LLC holds 25,000 shares of RDY stock, worth $348,250. This represents 0.23% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$348,250% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding RDY
# of Institutions
269Shares Held
102MCall Options Held
71KPut Options Held
22.5K-
Morgan Stanley New York, NY11.3MShares$157 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.10.7MShares$149 Million0.28% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$140 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$131 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$86.4 Million30.32% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.31B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...